Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
28.68
+1.14 (4.14%)
Apr 17, 2026, 1:25 PM HKT
HKG:1877 Market Cap
HKG:1877 has a market cap or net worth of 46.18 billion as of April 16, 2026. Its market cap has increased by 64.30% in one year.
Market Cap
46.18B
Enterprise Value
47.24B
Revenue
2.78B
Ranking
n/a
PE Ratio
n/a
Stock Price
28.68
Market Cap Chart
Since December 24, 2018, HKG:1877's market cap has increased from 18.06B to 46.18B, an increase of 155.74%. That is a compound annual growth rate of 13.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 45.46B | 31.18% |
| Dec 31, 2025 | 34.66B | 39.72% |
| Dec 31, 2024 | 24.81B | -37.28% |
| Dec 29, 2023 | 39.55B | -38.85% |
| Dec 30, 2022 | 64.67B | -7.04% |
| Dec 31, 2021 | 69.57B | -9.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RemeGen | 80.10B |
| 3SBio | 57.55B |
| Biocytogen Pharmaceuticals (Beijing) | 46.28B |
| Shanghai Henlius Biotech | 44.92B |
| InnoCare Pharma | 30.13B |
| Shanghai Bao Pharmaceuticals | 29.34B |
| Genscript Biotech | 27.79B |
| TransThera Sciences (Nanjing) | 27.75B |